Zelira Therapeutics achieves IRB approval for US clinical pain trial
Zelira Therapeutics (ASX:ZLD) (OTCMKTS:ZALDF) has achieved Institutional Review Board (IRB) endorsement for a pain observational preliminary to happen in the
Read moreZelira Therapeutics (ASX:ZLD) (OTCMKTS:ZALDF) has achieved Institutional Review Board (IRB) endorsement for a pain observational preliminary to happen in the
Read more